BioMedExperts, a niche social networking site, aims to help promote collaborative medical research and development among health care and life science researchers around the world.
|
Palo Alto-based Technology Partners launched a $300 million fund on Tuesday that it said will be split evenly between cleantech and life sciences investments.
|
Convincing U.S. venture capitalists to put cash into stem cell startups is a very tough task.
|
German government agency will match funds to help early-stage ventures.
|
Ablynx scores one of the year’s top European biotech deals.
|
As the life sciences industry matures, VCs need to go with the flow.
|
Global biotech and drug companies are outsourcing more research to India.
|
VC firm will invest $900 million in IT, life sciences, clean energy, pandemic preparedness, and bio defense.
|
New Enterprise Associates backs Supernus Pharmaceuticals. In other VC news:
|
NeoMed Management raises $124 million in its first fund since 2001.
|
High-tech firms raised $336 million in the third quarter, down 23 percent from the year-ago quarter.
|
Versant Ventures fund is aimed at early-stage life sciences companies.
|
Israeli startups raised $387 million in the second quarter of the year and are expected to raise $1.5 billion in 2005.
|